Reprogramming of CTLs into natural killer-like cells in celiac disease

Journal of Experimental Medicine

Volumn 203, Issue 5, 2006, Pages 1343-1355

  Meresse, Bertrand ^a   Curran, Shane A ^a,b   Ciszewski, Cezary ^a   Orbelyan, Gerasim ^a   Setty, Mala ^a   Bhagat, Govind ^b   Lee, Leanne ^a   Tretiakova, Maria ^a   Semrad, Carol ^a   Kistner, Emily ^a   Winchester, Robert J ^b   Braud, Veronique ^c   Lanier, Lewis L ^d   Geraghty, Daniel E ^e   Green, Peter H ^b   Guandalini, Stefano ^a   Jabri, Bana ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Columbia University ^*  (United States)

^c INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC FACTOR; NATURAL KILLER CELL RECEPTOR; PROTEIN KINASE ZAP 70; PROTEIN NKP44; PROTEIN NKP46; UNCLASSIFIED DRUG;

ARTICLE; CELIAC DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC LYMPHOCYTE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE;

BASE SEQUENCE; CELIAC DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTESTINAL MUCOSA; INTESTINE, SMALL; KILLER CELLS, NATURAL; LYMPHOMA; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 33646675580     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060028     Document Type: Article

References (67)

1. Jabri, B., and B. Meresse. 2006. NKG2 receptor-mediated regulation of effector CTL functions in the human tissue microenvironment. Curr. Top. Microbiol. Immunol. 298:139-156.
2. Roberts, A.I., L. Lee, E. Schwarz, V. Groh, T. Spies, E.C. Ebert, and B. Jabri. 2001. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167: 5527-5530.
3. Ogasawara, K., J.A. Hamerman, L.R. Ehrlich, H. Bour-Jordan, P. Santamaria, J.A. Bluestone, and L.L. Lanier. 2004. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity. 20:757-767.
4. Meresse, B., Z. Chen, C. Ciszewski, M. Tretiakova, G. Bhagat, T.N. Krausz, D.H. Raulet, L.L. Lanier, V. Groh, T. Spies, et al. 2004. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 21:357-366.
5. Hue, S., J.J. Mention, R.C. Monteiro, S. Zhang, C. Cellier, J. Schmitz, V. Verkarre, N. Fodil, S. Bahram, N. Cerf-Bensussan, and S. Caillat-Zucman. 2004. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 21:367-377.
6. Groh, V., A. Bruhl, H. El-Gabalawy, J.L. Nelson, and T. Spies. 2003. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 100:9452-9457.
7. Bauer, S., V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:727-729.
8. Cosman, D., J. Mullberg, C.L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N.J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 14:123-133.
9. Carayannopoulos, L.N., O.V. Naidenko, D.H. Fremont, and W.M. Yokoyama. 2002. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169:4079-4083.
10. Cerwenka, A., A.B. Bakker, T. McClanahan, J. Wagner, J. Wu, J.H. Phillips, and L.L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:721-727.
11. Diefenbach, A., J.K. Hsia, M.Y. Hsiung, and D.H. Raulet. 2003. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol. 33:381-391.
12. Wu, J., Y. Song, A.B. Bakker, S. Bauer, T. Spies, L.L. Lanier, and J.H. Phillips. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:730-732.
13. Rosen, D.B., M. Araki, J.A. Hamerman, T. Chen, T. Yamamura, and L.L. Lanier. 2004. A structural basis for the association of DAP12 with mouse, but not human, NKG2D. J. Immunol. 173:2470-2478.
14. Andre, P., R. Castriconi, M. Espeli, N. Anfossi, T. Juarez, S. Hue, H. Conway, F. Romagne, A. Dondero, M. Nanni, et al. 2004. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur. J. Immunol. 34:961-971.
15. Diefenbach, A., E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet. 2002. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3:1142-1149.
16. Gilfillan, S., E.L. Ho, M. Cella, W.M. Yokoyama, and M. Colonna. 2002. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3:1150-1155.
17. Fehniger, T.A., and M.A. Caligiuri. 2001. Interleukin 15: biology and relevance to human disease. Blood. 97:14-32.
18. Sollid, L.M. 2002. Coeliac disease: dissecting a complex inflammatory disorder. Nat. Rev. Immunol. 2:647-655.
19. Koning, F. 2005. Celiac disease: caught between a rock and a hard place. Gastroenterology. 129:1294-1301.
20. Marietta, E., K. Black, M. Camilleri, P. Krause, R.S. Rogers III, C. David, M.R. Pittelkow, and J.A. Murray. 2004. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J. Clin. Invest. 114:1090-1097.
21. Jabri, B., D.D. Kasarda, and P.H. Green. 2005. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol. Rev. 206: 219-231.
22. Green, P.H., and B. Jabri. 2003. Coeliac disease. Lancet. 362:383-391.
23. Maiuri, L., C. Ciacci, I. Ricciardelli, L. Vacca, V. Raia, A. Rispo, M. Griffin, T. Issekutz, S. Quaratino, and M. Londei. 2005. Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology. 129:1400-1413.
24. Lee, S.K., W. Lo, L. Memeo, H. Rotterdam, and P.H. Green. 2003. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest. Endosc. 57:187-191.
25. Wahab, P.J., J.W. Meijer, and C.J. Mulder. 2002. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am. J. Clin. Pathol. 118:459-463.
26. Forsberg, G., O. Hernell, S. Melgar, A. Israelsson, S. Hammarstrom, and M.L. Hammarstrom. 2002. Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology. 123:667-678.
27. Olaussen, R.W., F.E. Johansen, K.E. Lundin, J. Jahnsen, P. Brandtzaeg, and I.N. Farstad. 2002. Interferon-gamma-secreting T cells localize to the epithelium in coeliac disease. Scand. J. Immunol. 56:652-664.
28. Isaacson, P.G. 2000. Relation between cryptic intestinal lymphoma and refractory sprue. Lancet. 356:178-179.
29. Daum, S., C. Cellier, and C.J. Mulder. 2005. Refractory coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19:413-424.
30. Lanier, L.L., B. Corliss, J. Wu, and J.H. Phillips. 1998. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity. 8:693-701.
31. Tomasello, E., and E. Vivier. 2005. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Eur. J. Immunol. 35:1670-1677.
32. Braud, V.M., D.S. Allan, C.A. O'Callaghan, K. Soderstrom, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:795-799.
33. Lee, N., M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. Lopez-Botet, and D.E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA. 95:5199-5204.
34. Guma, M., L.K. Busch, L.I. Salazar-Fontana, B. Bellosillo, C. Morte, P. Garcia, and M. Lopez-Botet. 2005. The CD94/NKG2C killer lectinlike receptor constitutes an alternative activation pathway for a subset of CD8+ T cells. Eur. J. Immunol. 35:2071-2080.
35. Guma, M., A. Angulo, C. Vilches, N. Gomez-Lozano, N. Malats, and M. Lopez-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood. 104:3664-3671.
36. Jabri, B., J.M. Selby, H. Negulescu, L. Lee, A.I. Roberts, A. Beavis, M. Lopez-Botet, E.C. Ebert, and R.J. Winchester. 2002. TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity. 17:487-499.
37. Jabri, B., N.P. de Serre, C. Cellier, K. Evans, C. Gache, C. Carvalho, J.F. Mougenot, M. Allez, R. Jian, P. Desreumaux, et al. 2000. Selective expansion of intraepithelial lymphocytes expressing the HLA-E- specific natural killer receptor CD94 in celiac disease. Gastroenterology. 118: 867-879.
38. Arlettaz, L., J. Villard, C. de Rham, S. Degermann, B. Chapuis, B. Huard, and E. Roosnek. 2004. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes. Eur. J. Immunol. 34:3456-3464.
39. Lopez-Botet, M., J.J. Perez-Villar, M. Carretero, A. Rodriguez, I. Melero, T. Bellon, M. Llano, and F. Navarro. 1997. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol. Rev. 155:165-174.
40. Kaiser, B.K., F. Barahmand-Pour, W. Paulsene, S. Medley, D.E. Geraghty, and R.K. Strong. 2005. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J. Immunol. 174:2878-2884.
41. Brumbaugh, K.M., J.J. Perez-Villar, C.J. Dick, R.A. Schoon, M. Lopez-Botet, and P.J. Leibson. 1996. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J. Immunol. 157:2804-2812.
42. Rinke de Wit, T.F., S. Vloemans, P.J. van den Elsen, A. Haworth, and P.L. Stern. 1990. Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines. J. Immunol. 144:1080-1087.
43. Cellier, C., N. Patey, L. Mauvieux, B. Jabri, E. Delabesse, J.P. Cervoni, M.L. Burtin, D. Guy-Grand, Y. Bouhnik, R. Modigliani, et al. 1998. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 114:471-481.
44. Vitale, M., C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta. 1998. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:2065-2072.
45. Lanier, L.L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359-393.
46. Raulet, D.H., R.E. Vance, and C.W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330.
47. Yokoyama, W.M., and B.F. Plougastel. 2003. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3:304-316.
48. Chiesa, S., E. Tomasello, E. Vivier, and F. Vely. 2005. Coordination of activating and inhibitory signals in natural killer cells. Mol. Immunol. 42:477-484.
49. Curran, S.A., O.M. FitzGerald, P.J. Costello, J.M. Selby, D.J. Kane, B. Bresnihan, and R. Winchester. 2004. Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J. Immunol. 172:1935-1944.
50. Biassoni, R., C. Cantoni, D. Pende, S. Sivori, S. Parolini, M. Vitale, C. Bottino, and A. Moretta. 2001. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181:203-214.
51. Lanier, L.L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
52. Brooks, C.G. 1983. Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes. Nature. 305:155-158.
53. Brooks, C.G., M. Holscher, and D. Urdal. 1985. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen. J. Immunol. 135:1145-1152.
54. Shustik, C., I.R. Cohen, R.S. Schwartz, E. Latham-Griffin, and S.D. Waksal. 1976. T lymphocytes with promiscuous cytotoxicity. Nature. 263:699-701.
55. Farstad, I.N., F.E. Johansen, L. Vlatkovic, J. Jahnsen, H. Scott, O. Fausa, A. Bjorneklett, P. Brandtzaeg, and T.S. Halstensen. 2002. Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression. Gut. 51:372-378.
56. Mention, J.J., M. Ben Ahmed, B. Begue, U. Barbe, V. Verkarre, V. Asnafi, J.F. Colombel, P.H. Cugnenc, F.M. Ruemmele, E. McIntyre, et al. 2003. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology. 125:730-745.
57. Karre, K. 2002. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55:221-228.
58. McMahon, C.W., and D.H. Raulet. 2001. Expression and function of NK cell receptors in CD8+ T cells. Curr. Opin. Immunol. 13:465-470.
59. Ortega, C., P. Romero, A. Palma, T. Orta, J. Pena, A. Garcia-Vinuesa, I.J. Molina, and M. Santamaria. 2004. Role for NKG2-A and NKG2-C surface receptors in chronic CD4+ T-cell responses. Immunol. Cell Biol. 82:587-595.
60. Taunk, J., A.I. Roberts, and E.C. Ebert. 1992. Spontaneous cytotoxicity of human intraepithelial lymphocytes against epithelial cell tumors. Gastroenterology. 102:69-75.
61. Lee, N., D.R. Goodlett, A. Ishitani, H. Marquardt, and D.E. Geraghty. 1998. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:4951-4960.
62. Ishitani, A., N. Sageshima, N. Lee, N. Dorofeeva, K. Hatake, H. Marquardt, and D.E. Geraghty. 2003. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J. Immunol. 171: 1376-1384.
63. Rubio, V., T.B. Stuge, N. Singh, M.R. Betts, J.S. Weber, M. Roederer, and P.P. Lee. 2003. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9:1377-1382.
64. Bryceson, Y.T., M.E. March, D.F. Barber, H.G. Ljunggren, and E.O. Long. 2005. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 202:1001-1012.
65. Li, X., R.J. Quigg, J. Zhou, J.T. Ryaby, and H. Wang. 2005. Early signals for fracture healing. J. Cell. Biochem. 95:189-205.
66. Arden, B., S.P. Clark, D. Kabelitz, and T.W. Mak. 1995. Human T-cell receptor variable gene segment families. Immunogenetics. 42:455-500.
67. Lefranc, M.P., V. Giudicelli, Q. Kaas, E. Duprat, J. Jabado-Michaloud, D. Scaviner, C. Ginestoux, O. Clement, D. Chaume, and G. Lefranc. 2005. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 33:D593-D597.